Perspective Therapeutics, Inc.CATXNYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+213.0%
5Y CAGR+123.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+213.0%/yr
vs +15.3%/yr prior
5Y CAGR
+123.6%/yr
Recent acceleration
Acceleration
+197.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
55.9x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $79.77M | +91.6% |
| 2024 | $41.64M | +95.4% |
| 2023 | $21.31M | +719.0% |
| 2022 | $2.60M | +0.8% |
| 2021 | $2.58M | +80.9% |
| 2020 | $1.43M | +26.7% |
| 2019 | $1.13M | -23.6% |
| 2018 | $1.47M | -15.6% |
| 2017 | $1.75M | +80.9% |
| 2016 | $965000.00 | - |